Business
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025
FRANKFURT, Germany, October 27, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of drug development during CPHI Frankfurt 2025 (October 28–30, booth #5.1A8, Hall 5.1). Leaders from across the organization will participate in a series of panel discussions highlighting industry trends, sustainability strategies and how collaboration can accelera
About this update from Thermo Fisher Scientific Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1590,"height":341,"url":"https://media.zenfs.com/en/business-wire.com/97969746f3184493844dc6226d308bd6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KvSdJvJqfOoR9j0aSfUPQA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/97969746f3184493844dc6226d308bd6","width":960,"height":206},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/GSphorJjdBhRlmdtSejVvQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MTQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/97969746f3184493844dc6226d308bd6","width":1200,"height":257}},"lazy":false},{"type":"text","content":"Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges","length":144,"tagName":"p","attribs":{}},{"type":"text","content":"FRANKFURT, Germany, October 27, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of drug development during CPHI Frankfurt 2025 (October 28–30, booth #5.1A8, Hall 5.1). Leaders from across the organization will participate in a series of panel discussions highlighting industry trends, sustainability strategies and how collaboration can accelerate delivery of life-changing medicines to market.","length":566,"tagName":"p"},{"type":"text","content":""Our goal is to streamline the drug discovery, development and manufacturing process to help customers provide the highest quality treatments to patients in need, both safely and efficiently," said Michael Shafer, executive vice president and president, biopharma services, Thermo Fisher Scientific. "Throughout the past year, we continued to leverage the breadth and depth of our offerings and expertise to do so – not only as the preferred partner between discovery and delivery but also by providing innovative solutions, including Accelerator™ Drug Development, that allow our pharma and biotech partners to mitigate risks as they tackle global health challenges."","length":688,"tagName":"p"},{"type":"text","content":"Continuing Efforts to Simplify Drug Discovery &...